DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER

« Back to Dashboard

Clinical Trials for Brevibloc Double Strength In Plastic Container

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01114971	Labetalol and Esmolol: Vital Signs and Post Operative Pain Management	Recruiting	Cedars-Sinai Medical Center	Phase 4	2009-09-01	This study proposes to investigate the effects of labetalol or esmolol on managing the vital signs (like blood pressure and heart rate) during surgery, on pain management, and on the later recovery after surgery. It will also assess the cost-effectiveness of Labetalol and esmolol for outpatient surgery.
NCT01179113	Esmolol Infusion During Laminectomy: Effect on Quality of Recovery	Terminated	Cedars-Sinai Medical Center	Phase 4	2011-06-01	The purpose of this study is to evaluate the effects of esmolol, a drug which is commonly administered during surgery to help control blood pressure and heart rate, on postoperative pain levels and requirements for pain medication.
NCT01208402	Esmolol for Treatment of Perioperative Tachycardia	Terminated	Baxter Healthcare Corporation	Phase 3	2010-09-01	The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.
NCT01208402	Esmolol for Treatment of Perioperative Tachycardia	Terminated	Duke University	Phase 3	2010-09-01	The purpose of this study is to find out if Esmolol is a safe and effective alternative treatment compared to standard treatment using a long acting beta blocker drug, in controlling abnormal heart rate before, during and immediately after surgery.

Clinical Trial Conditions for Brevibloc Double Strength In Plastic Container

Condition Name

Condition Name for Brevibloc Double Strength In Plastic Container
Intervention	Trials
Septic Shock	3
Myocardial Reperfusion Injury	1
Hemorrhagic Stroke	1
Myocardial Ischemia	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Brevibloc Double Strength In Plastic Container
Intervention	Trials
Shock, Septic	3
Shock	3
Tachycardia	2
Myocardial Infarction	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Brevibloc Double Strength In Plastic Container

Trials by Country

Trials by Country for Brevibloc Double Strength In Plastic Container
Location	Trials
United States	8
Brazil	6
Turkey	3
France	1
Czech Republic	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Brevibloc Double Strength In Plastic Container
Location	Trials
California	2
Utah	2
North Carolina	1
Maryland	1
Michigan	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Brevibloc Double Strength In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Brevibloc Double Strength In Plastic Container
Clinical Trial Phase	Trials
Phase 4	7
Phase 3	1
Phase 2	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Brevibloc Double Strength In Plastic Container
Clinical Trial Phase	Trials
Recruiting	6
Unknown status	3
Terminated	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Brevibloc Double Strength In Plastic Container

Sponsor Name

Sponsor Name for Brevibloc Double Strength In Plastic Container
Sponsor	Trials
Cedars-Sinai Medical Center	2
Beth Israel Deaconess Medical Center	2
Diskapi Teaching and Research Hospital	2

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Brevibloc Double Strength In Plastic Container
Sponsor	Trials
Other	17
Industry	4

Export unavailable in trial.
Subscribe for complete access.